We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+23.43%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$16.4B
AUM Growth
-$5.58B
Cap. Flow
-$3.87B
Cap. Flow %
-23.65%
Top 10 Hldgs %
18.07%
Holding
3,458
New
283
Increased
974
Reduced
1,077
Closed
907

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$114M
2
BMY icon
Bristol-Myers Squibb
BMY
+$109M
3
TT icon
Trane Technologies
TT
+$106M
4
MSFT icon
Microsoft
MSFT
+$104M
5
MA icon
Mastercard
MA
+$104M

Sector Composition

Rank Sector Weight
1 Technology 23.03%
2 Healthcare 13.89%
3 Financials 11.27%
4 Consumer Discretionary 8.92%
5 Industrials 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MPLX icon
451
MPLX
MPLX
$60.1B
$2.69M 0.02%
155,779
-18,049
-10% -$308K
TTEK icon
452
Tetra Tech
TTEK
$8.7B
$2.66M 0.02%
168,210
-106,165
-39% -$1.61M
INGR icon
453
Ingredion
INGR
$6.48B
$2.62M 0.02%
31,573
-3,030
-9% -$248K
BTI icon
454
British American Tobacco
BTI
$134B
$2.6M 0.02%
67,007
-27,412
-29% -$1.05M
IWS icon
455
iShares Russell Mid-Cap Value ETF
IWS
$15.8B
$2.58M 0.02%
33,683
-21,297
-39% -$1.55M
FLIR
456
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
$2.56M 0.02%
63,058
+16,399
+35% +$681K
DOV icon
457
Dover
DOV
$27.4B
$2.55M 0.02%
26,425
-1,260
-5% -$116K
FAF icon
458
First American
FAF
$8.08B
$2.54M 0.02%
52,881
+15,621
+42% +$738K
HDV
459
iShares Core High Dividend ETF
HDV
$14.7B
$2.52M 0.02%
155,595
-10,550
-6% -$170K
IJS icon
460
iShares S&P Small-Cap 600 Value ETF
IJS
$8.2B
$2.5M 0.02%
41,628
-114
-0.3% -$6.39K
EMN icon
461
Eastman Chemical
EMN
$7.79B
$2.5M 0.02%
35,912
+24,299
+209% +$1.53M
ORLY icon
462
O'Reilly Automotive
ORLY
$75.6B
$2.47M 0.02%
87,990
-308,130
-78% -$8.05M
GWW icon
463
W.W. Grainger
GWW
$66B
$2.47M 0.02%
7,869
-1,053
-12% -$304K
CHE icon
464
Chemed
CHE
$6.87B
$2.46M 0.02%
5,467
-253
-4% -$113K
TSM icon
465
TSMC
TSM
$2.03T
$2.43M 0.01%
42,800
+27,961
+188% +$1.47M
PWR icon
466
Quanta Services
PWR
$88.3B
$2.42M 0.01%
61,685
+18,903
+44% +$674K
HEI.A icon
467
HEICO Corp Class A
HEI.A
$36.8B
$2.35M 0.01%
28,912
-1,336
-4% -$104K
LIN icon
468
Linde
LIN
$236B
$2.33M 0.01%
10,975
-2,005
-15% -$387K
MPT
469
Medical Properties Trust
MPT
$2.89B
$2.33M 0.01%
123,811
+121,311
+4,852% +$2.15M
AEP icon
470
American Electric Power
AEP
$72.4B
$2.32M 0.01%
29,115
-317
-1% -$25.9K
NUE icon
471
Nucor
NUE
$60.5B
$2.31M 0.01%
55,770
-85,883
-61% -$3.47M
SCI icon
472
Service Corp International
SCI
$11.7B
$2.29M 0.01%
58,976
+58,736
+24,473% +$2.26M
HPE icon
473
Hewlett Packard
HPE
$60.4B
$2.27M 0.01%
233,030
-1,534,051
-87% -$15.1M
TFC icon
474
Truist Financial
TFC
$64.7B
$2.23M 0.01%
59,530
-216,498
-78% -$7.8M
CPB icon
475
Campbell Soup
CPB
$6.8B
$2.22M 0.01%
44,762
-6,176
-12% -$307K

Similar funds

Glenmede Trust's Q2 2020 Portfolio in Review

As of Q2 2020, Glenmede Trust held 3,458 positions worth $16.4B, down 25% from $21.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Glenmede Trust withdrew a net $3.87B in Q2 2020, closing 907 positions and reducing 1,077 holdings. Its most notable exit was Raytheon Company, an estimated $66.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Glenmede Trust opened a new position in Carrier Global worth $21.3M.

  • Glenmede Trust's largest Q2 2020 buy was Carrier Global: 960,042 shares worth $21.3M.
  • Glenmede Trust added most to State Street SPDR S&P 500 ETF Trust in Q2 2020, an estimated $97.1M increase.
  • Glenmede Trust's biggest Q2 2020 reduction was Accenture, cutting an estimated $114M.
  • Glenmede Trust fully exited Raytheon Company in Q2 2020, selling an estimated $66.5M.
  • Glenmede Trust's ten largest holdings make up 18% of its $16.4B portfolio in Q2 2020.
  • Glenmede Trust opened 283 new positions and closed 907 in Q2 2020.
  • Glenmede Trust's portfolio value fell 25% quarter-over-quarter to $16.4B.

Based on Glenmede Trust's 13F filing for Q2 2020, filed 14 Aug 2020.